First Manhattan CO Guardant Health, Inc. Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $8,871 - $12,043	-100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $9,877 - $13,216	100 New	100 $12,000
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $3,298 - $4,485	-33 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $2,650 - $3,689	33 New	33 $3,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.